Table 2.
Groups | gestational age<35wks | gestational age≥35wks | ||||
---|---|---|---|---|---|---|
n | PIVH | incidence (%) | n | PIVH | incidence (%) | |
corticosteroid use | 155 | 82 | 52.9 | 51 | 17 | 33.3 |
non corticosteroid use | 597 | 399 | 66.8 | 319 | 121 | 37.9 |
χ2 | 4.30 | 0.180 | ||||
P | 0.038 | 0.671 |
Groups | gestational age<35wks | gestational age≥35wks | ||||
---|---|---|---|---|---|---|
n | PIVH | incidence (%) | n | PIVH | incidence (%) | |
corticosteroid use | 155 | 82 | 52.9 | 51 | 17 | 33.3 |
non corticosteroid use | 597 | 399 | 66.8 | 319 | 121 | 37.9 |
χ2 | 4.30 | 0.180 | ||||
P | 0.038 | 0.671 |